A Big Prospect for Hydrogel Nano-System in Glioma
DOI: https://doi.org/10.2147/ijn.s470315
IF: 7.033
2024-06-11
International Journal of Nanomedicine
Abstract:Lu Zhang, 1– 3, &ast Fei Teng, 1, 2, &ast Huajie Xin, 1, 2 Wei Xu, 1, 2 Wei Wu, 4 Chenguo Yao, 3 Zhiqiang Wang 1, 2 1 Key Laboratory for Biorheological Science and Technology of Ministry of Education (Chongqing University), Chongqing University Cancer Hospital, Chongqing, 400030, People's Republic of China; 2 Center of Thoracic Cancer, Chongqing University Cancer Hospital, Chongqing, 400030, People's Republic of China; 3 The State Key Laboratory of Power Transmission Equipment and System Security and New Technology, College of Electrical Engineering, Chongqing University, Chongqing, 400044, People's Republic of China; 4 College of Biological Engineering, Chongqing University, Chongqing, 400030, People's Republic of China &astThese authors contributed equally to this work Correspondence: Lu Zhang; Zhiqiang Wang, Chongqing University Cancer Hospital, No. 181 Hanyu Road, Shapingba District, Chongqing, 400030, People's Republic of China, Email ; Patients diagnosed with glioma typically face a limited life expectancy (around 15 months on average), a bleak prognosis, and a high likelihood of recurrence. As such, glioma is recognized as a significant form of malignancy. Presently, the treatment options for glioma include traditional approaches such as surgery, chemotherapy, and radiotherapy. Regrettably, the efficacy of these treatments has been less than optimal. Nevertheless, a promising development in glioma treatment lies in the use of hydrogel nano-systems as sophisticated delivery systems. These nano-systems have demonstrated exceptional therapeutic effects in the treatment of glioma by various responsive ways, including temperature-response, pH-response, liposome-response, ROS-response, light-response, and enzyme-response. This study seeks to provide a comprehensive summary of both the therapeutic application of hydrogel nano-systems in managing glioma and the underlying immune action mechanisms. Keywords: glioma, hydrogel nano-system, immunotherapy, tumor immune microenvironment Graphical Brain tumors, especially glioma, represent a highly malignant form of cancer with a propensity for recurrence, drug resistance, and metastasis. 1 Current treatment methods for glioma primarily involve surgery, chemotherapy, and radiotherapy. 2 However, the effectiveness of these conventional approaches is limited. Tumor recurrence often follows surgical resection, chemotherapy drugs struggle to penetrate the blood-brain barrier (BBB), leading to significant side effects, and radiotherapy may harm normal brain tissue and impair brain function. 3 To address these challenges, researchers have explored various drug carriers, such as liposomes, to improve drug delivery across the BBB. Although liposomes possess the advantage of traversing the BBB, their short half-life in the body hampers their ability to achieve high drug concentrations at the tumor site. 4 Another approach involves utilizing biomimetic membranes to prolong the retention of therapeutic agents at the tumor site by evading immune clearance mechanisms. However, previous attempts have been undermined by the tumor microenvironment (TME), which contributes to the frequent recurrence of glioma. 5 In addition, there are some conventional nano-materials, which have some evident drawbacks, such as significant side effects, 6 poor biocompatibility, 7 and lack of targeting specificity. 8 A novel nano-material, hydrogel, has emerged as a promising candidate for glioma therapy. Hydrogel-based nano-systems have demonstrated broad applications in the management of brain tumors. 9–11 Notably, a polypeptide hydrogel was injected into a mouse glioma model, induced CD 8+ T cell responses, promoted M1 macrophage polarization, regulated the expression of hypoxia-inducible factor 1 alpha (HIF1-α), programmed cell death ligand 1 (PDL1), and C-X-C motif chemokine ligand 9 (CXCL9), and reshaped the tumor immune microenvironment (TIME) to inhibit tumor growth. 12 Recent research confirms that nano-hydrogel system injected into a mouse glioma model following tumor resection, improved antigen presentation, activated CD 8+ T cells and NK cells, reversed the immunosuppressive TME, and inhibited tumor recurrence. 9 In addition, studies have shown that utilizing a silk fibroin (SF) hydrogel coupled with a photosensitizer to interfere with a mouse glioma model and observed anti-glioma effects. 13 Consequently, the hydrogel nano-system holds tremendous promise as a novel and innovative approach for the treatment of glioma. The BBB is a uniqu -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology